F
$ Value
$784K
Shares
3,788
Price
$207
Filed
Feb 20
Insider
Name
Davis J. E.
Title
CEO and President
CIK
0001599837
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-18
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
130,153
Footnotes
Represents an award of restricted stock units. | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. | The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Filing Info
Davis J. E.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | DGX | A | $10.6M |
| 2026-03-04 | DGX | F | $5.4M |
| 2026-03-02 | DGX | F | $608K |
| 2026-03-02 | DGX | ▼ | $2.1M |
| 2026-02-18 | DGX | A | $0 |
| 2026-02-18 | DGX | F | $503K |
| 2026-02-18 | DGX | F | $784K |
| 2026-02-18 | DGX | A | $0 |
| 2025-11-25 | DGX | M | $5.3M |
| 2025-11-25 | DGX | ▼ | $1.8M |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $1.1M | 2026-03-05 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $2.0M | 2026-03-05 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $7.0M | 2026-03-05 |
|
Davis J. E.
CEO and President
|
— | $2.1M | 2026-03-04 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-03-04 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-03-04 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | $538K | 2026-03-04 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-03-04 |